Tezacaftor
Sponsors
Vertex Pharmaceuticals Incorporated
Conditions
Cystic Fibrosis
Phase 1
A Study to Evaluate Safety and Pharmacokinetics of VX-659 in Healthy Subjects and in Adults With Cystic Fibrosis
CompletedNCT03029455
Start: 2016-11-30End: 2017-08-31Updated: 2017-09-05
Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis
CompletedNCT06154447
Start: 2023-12-12End: 2026-07-10Updated: 2026-08-10